Posted by evenintherain on March 13, 2010, at 13:41:38
In reply to Re: My letter to the FDA » detroitpistons, posted by ed_uk2010 on March 13, 2010, at 9:20:21
Hi, here is her response.
She is going to give some serious thought on how to bring the SNRI discontinuation issue to the proper people at the FDA. She is also going to find out to what extent they are already looking at this issue.
in the meantime, anyone who has complaints should definitely register them here: http://www.fda.gov/safety/MedWatch/default.htm
MedWatch is the registry for all adverse events.
The doctor who is head of psychopharm for the FDA and steers the committee is Dr. Thomas Laughren. His contact info is below. Definitely have people concerned about this issue contact him. He is, after all, a public servant. And this is his missive.
Laughren, Thomas P
SUPERVISORY MEDICAL OFFICER
Silver Spring MD 20993
Anyway, my aunt is taking this very seriously and did experience discontinuation syndrome herself (with cymbalta) so knows it needs to be addressed. i am glad you got me to contact her!
she added "BTW, I do remember getting [someone's] very thoughtful email on this issue addressed to the committee writ large, so obviously the FDA forwarded it to all of the members of the committee."